CORRESP Filing
Pasithea Therapeutics Corp.
Date: Nov. 19, 2025 · CIK: 0001841330 · Accession: 0001213900-25-112468
AI Filing Summary & Sentiment
File numbers found in text: 333-291611
Show Raw Text
CORRESP
1
filename1.htm
November
19, 2025
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street NE
Washington,
D.C. 20549
Re:
Pasithea
Therapeutics Corp.
Registration
Statement on Form S-1
File
No. 333-291611
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co.,
LLC ("Wainwright"), as placement agent on a best-efforts basis, hereby joins Pasithea Therapeutics Corp. in requesting that
the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-291611)
(the "Registration Statement") to become effective on Thursday, November 20, 2025, at 5:15 p.m., Eastern Time, or as soon
as practicable thereafter. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best
efforts offering pursuant to the Registration Statement.
[Signature
Page Follows]
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/
Edward Silvera
Name:
Edward Silvera
Title:
Chief Operating Officer
[Signature
Page to Acceleration Request]